Brinker Capital’s AngioDynamics ANGO Stock Holding History

Brinker Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$678K	Buy	66,675 +15,938	+31%	+$164K	0.02%	620
2020 Q1	$529K	Buy	50,737 +31,262	+161%	+$392K	0.02%	621
2019 Q4	$312K	Sell	19,475 -5,846	-23%	-$89.3K	0.01%	825
2019 Q3	$466K	Sell	25,321 -6,677	-21%	-$131K	0.02%	718
2019 Q2	$630K	Buy	+31,998	New	+$652K	0.02%	619
2018 Q3	–	Sell	-12,574	Closed	-$280K	–	980
2018 Q2	$280K	Sell	12,574 -324	-3%	-$6.62K	0.01%	886
2018 Q1	$222K	Sell	12,898 -5,239	-29%	-$87.4K	0.01%	947
2017 Q4	$302K	Buy	18,137 +3,198	+21%	+$54.6K	0.01%	848
2017 Q3	$255K	Sell	14,939 -554	-4%	-$9.31K	0.01%	851
2017 Q2	$251K	Buy	15,493 +1,461	+10%	+$23.1K	0.01%	621
2017 Q1	$243K	Buy	+14,032	New	+$235K	0.01%	844

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Brinker Capital's ANGO Position: Q2 2020 in Review

Brinker Capital increased its AngioDynamics (ANGO) stake by 31% in Q2 2020, buying an estimated $164K and bringing the position to 66,675 shares worth $678K. The position accounts for 0.02% of the portfolio, ranked #620.

Brinker Capital first reported a position in ANGO in Q1 2017 and has held it in 11 quarters since. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

Brinker Capital held 66,675 shares of AngioDynamics worth $678K as of Q2 2020.
Brinker Capital bought 15,938 AngioDynamics shares in Q2 2020, an estimated $164K.
AngioDynamics made up 0.02% of Brinker Capital's portfolio in Q2 2020, its #620 holding.
Brinker Capital first reported a position in AngioDynamics in Q1 2017 and has held it in 11 quarters since.
146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.